Sustained and Subsequent Response to Atogepant Among Individuals With Chronic Migraine: Post Hoc Analysis of the PROGRESS Trial

被引：0
|
作者：
Lipton, R. [1 ]
Chalermpalanupap, N. [2 ]
Nahas-Geiger, S. [3 ]
Pozo-Rosich, P. [4 ]
McAllister, P. [5 ]
Tatsuoka, Y. [6 ]
Liu, Y. [7 ]
Dabruzzo, B. [2 ]
Smith, J. [7 ]
Bilchik, T. [8 ]
机构：
[1] Albert Einstein Coll Med, Bronx, NY USA
[2] AbbVie, Madison, NJ USA
[3] Thomas Jefferson Univ, Dept Neurol, Jefferson Headache Ctr, Philadelphia, PA USA
[4] Univ Calif Los Angeles, Los Angeles, CA USA
[5] New England Inst Neurol & Headache, Stamford, CT USA
[6] Tatsuoka Neurol Clin, Kyoto, Japan
[7] AbbVie, N Chicago, IL USA
[8] Yale Sch Med, New Haven, CT USA
来源：
HEADACHE | 2023年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P-180
引用
收藏
页码：168 / 169
页数：2
相关论文
共 50 条
  • [41] Responder Rates to OnabotulinumtoxinA in Patients With Chronic Migraine: A Post Hoc Analysis of the COMPEL Study
    Rothrock, J. F.
    Luo, L.
    Eross, E. J.
    Sommer, K.
    Blumenfeld, A. M.
    HEADACHE, 2020, 60 : 93 - 93
  • [42] Likelihood of response with subsequent dosing for patients with migraine and initial suboptimal response with eptinezumab: A post hoc analysis of two placebo-controlled randomized clinical trials
    Schim, Jack D.
    Anderson, Carlton
    Brunner, Elizabeth
    Hirman, Joe
    Ogbru, Annette
    Cady, Roger
    McGill, Lora
    HEADACHE, 2022, 62 (05): : 558 - 565
  • [43] Baseline Predictors of Clinical Response: A Post Hoc Analysis of the Ambition Trial
    Benza, Raymond
    Blair, Christiana
    Patel, Krishna
    Eads, Michael
    CHEST, 2017, 152 (04) : 1052A - 1052A
  • [44] Intravenous Fluids for Acute Migraine. a Post-hoc Analysis of Clinical Trial Data
    Friedman, B.
    Balbin, J.
    HEADACHE, 2015, 55 : 138 - 138
  • [45] Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
    Shigekazu Kitamura
    Takao Takeshima
    Daishi Yui
    Gabriel Paiva da Silva Lima
    Reija Koukakis
    Cheng Peng
    Ryuji Yoshida
    Yotaro Numachi
    Miki Hasebe
    Neurology and Therapy, 2023, 12 (6) : 1993 - 2006
  • [46] Efficacy of Erenumab for Migraine Prevention in Japanese Patients with Episodic and Chronic Migraine: Results of a Post-Hoc Pooled Analysis
    Kitamura, Shigekazu
    Takeshima, Takao
    Yui, Daishi
    Lima, Gabriel Paiva da Silva
    Koukakis, Reija
    Peng, Cheng
    Yoshida, Ryuji
    Numachi, Yotaro
    Hasebe, Miki
    NEUROLOGY AND THERAPY, 2023, 12 (06) : 1993 - 2006
  • [47] Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
    Wang, Shuu-Jiun
    Kim, Byung-Kun
    Wang, Hebo
    Zhou, Jiying
    Wan, Qi
    Yu, Tingmin
    Lian, Yajun
    Arkuszewski, Michal
    Ecochard, Laurent
    Snellman, Josefin
    Wen, Shihua
    Yin, Fangfang
    Li, Zheng
    Su, Wendy
    Yu, Shengyuan
    HEADACHE, 2025, 65 (01): : 143 - 152
  • [48] Effect of erenumab on the reversion from chronic migraine to episodic migraine in an Asian population: A post hoc analysis of the DRAGON study
    Wang, Shuu-Jiun
    Kim, Byung-Kun
    Wang, Hebo
    Zhou, Jiying
    Wan, Qi
    Yu, Tingmin
    Lian, Yajun
    Arkuszewski, Michal
    Ecochard, Laurent
    Snellman, Josefin
    Wen, Shihua
    Yin, Fangfang
    Li, Zheng
    Su, Wendy
    Yu, Shengyuan
    HEADACHE, 2025, 65 (01): : 143 - 152
  • [49] Responder Rates to Atogepant in Patients With Episodic Migraine: A Post Hoc Analysis of Results From a Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled Trial
    Dodick, David W.
    Ailani, Jessica
    Goadsby, Peter J.
    Trugman, Joel M.
    Finnegan, Michelle
    Lakkis, Hassan
    Li, Ye
    Szegedi, Armin
    CEPHALALGIA, 2019, 39 : 183 - 184
  • [50] Predictors of Clinical Response to Intravenous Secukinumab Among Patients with PsA: A Post Hoc Analysis of a Phase 3 Trial
    Kivitz, Alan
    Sedova, Liliana
    Churchill, Melvin
    Vizcaya, Cynthia
    Sutariya, Reema
    Cao, Wenhao
    Singhal, Atul
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4750 - 4752
12345